Advertisement

Impact of the COVID -19 pandemic on the organisation of breast reconstruction in France

Published:September 19, 2020DOI:https://doi.org/10.1016/j.bjps.2020.08.114
      Since the beginning of the COVID-19 pandemic, the health emergency has justified giving priority to the carcinologic management of breast cancer patients at the expense of breast reconstruction (BR). BR activity was abruptly threatened or even interrupted, generating a waiting list of patients.
      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Journal of Plastic, Reconstructive & Aesthetic Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Gligorov J.
        • Bachelot T.
        • Pierga J.-.Y.
        • et al.
        COVID-19 et personnes suivies pour un cancer du sein : recommandations françaises pour la pratique clinique de Nice-St Paul de Vence, en collaboration avec le Collège Nationale des Gynécologues et Obstétriciens Français (CNGOF), la Société d'Imagerie de la Femme (SIFEM), la Société Française de Chirurgie Oncologique (SFCO), la Société Française de Sénologie et Pathologie Mammaire (SFSPM) et le French Breast Cancer Intergroup-UNICANCER (UCBG).
        Bull Cancer (Paris). 2020; 107: 528-537
        • Curigliano G.
        • Cardoso M.J.
        • Poortmans P.
        • et al.
        Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic.
        The Breast. 2020; 52: 8-16
      1. COVID19-Breast-Reconstruction-Statement. pdf [Internet]. [cited 2020 Jun 5]. Available from:https://www.plasticsurgery.org/documents/medical-professionals/COVID19-Breast-Reconstruction-Statement.pdf

        • Rubino F.
        • Cohen R.V.
        • Mingrone G.
        • et al.
        Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients and prioritisation of access to surgery.
        Lancet Diabetes Endocrinol. 2020; (S2213858720301571)
        • Régis C.
        • Le J.
        • Chauvet M.-.P.
        • Le Deley M.-.C.
        • Le Teuff G
        Variations in the breast reconstruction rate in France: a nationwide study of 19,466 patients based on the French medico-administrative database.
        The Breast. 2018; 42: 74-80